Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.
about
Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.Cost-effectiveness comparison between neoadjuvant chemohormonal therapy and extended pelvic lymph node dissection in high-risk prostate cancer patients treated with radical prostatectomy: a multi-institutional analysis.Role of robot-assisted radical prostatectomy in locally advanced prostate cancer.
P2860
Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Efficacy of a neoadjuvant gona ...... cancer: a single-center study.
@en
Efficacy of a neoadjuvant gona ...... cancer: a single-center study.
@nl
type
label
Efficacy of a neoadjuvant gona ...... cancer: a single-center study.
@en
Efficacy of a neoadjuvant gona ...... cancer: a single-center study.
@nl
prefLabel
Efficacy of a neoadjuvant gona ...... cancer: a single-center study.
@en
Efficacy of a neoadjuvant gona ...... cancer: a single-center study.
@nl
P2093
P2860
P1476
Efficacy of a neoadjuvant gona ...... cancer: a single-center study.
@en
P2093
Atsushi Imai
Chikara Ohyama
Hayato Yamamoto
Kazuhisa Hagiwara
Shingo Hatakeyama
Takahiro Yoneyama
Takuya Koie
Tohru Yoneyama
Yasuhiro Hashimoto
Yuki Tobisawa
P2860
P304
P356
10.1007/S11255-017-1546-6
P577
2017-02-17T00:00:00Z